Biodesix GAAP EPS of -$0.08 misses by $0.01, revenue of $20M beats by $1.53M

Stock Information for Biodesix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biodesix Inc.

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
Biodesix Announces Third Quarter 2025 Results and Highlights
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital(TM) PCR High Complexity Assays
Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
Biodesix Announces One-for-Twenty Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.